NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY

简称 N-S ARCH PHARMACOL ·GERMANY ·出版周期 Monthly ·年均收录 120 篇

3.1

最新影响因子

16.20%

自引率

较易

投稿难度

偏慢,4-8周

审稿周期

期刊简介

NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY是一本国际知名的药理学杂志，ISSN号为0028-1298，由德国Springer出版社出版，出版地为德国，出版周期为月刊。该杂志的影响因子根据最新数据在2-3之间，属于非开放获取（非OA）期刊，并被SCI收录，在中科院分区中通常位于医学或药理学领域的3区或4区。该杂志的发文特点主要集中在实验药理学和毒理学领域，涵盖药物作用机制、药代动力学、药效学以及毒理学研究，尤其关注基础与临床药理学的前沿进展。杂志的质量较高，以严格的同行评审和学术严谨性著称，但影响因子相对中等，可能在某些高竞争领域吸引力有限，投稿时需注意研究内容与期刊范围的契合度以避免拒稿风险。总体而言，该杂志是药理学领域值得信赖的传统期刊，适合发表基础性和机制性研究。

影响因子趋势

近期发表

Indole–benzimidazole hybrids modulate lipid metabolism and promote autophagic and apoptotic signaling in breast cancer 2026-09-11

ZhuJing Pill retards lens-induced myopia progression by improving ciliary muscle mitochondrial function via KEAP1/NRF2–TGF-β axis 2026-09-11

A multifunctional hydrogel dressing for wound healing and in vitro cytotoxicity against breast cancer cells: association with GRP78 expression 2026-09-11

Multi-database pharmacovigilance identifies disproportionate reporting of hepatobiliary events with avacopan: an integrative study with network pharmacology and interpretable machine learning 2026-09-10

Effects of perioperative MESNA on lipid peroxidation and myocardial injury in patients undergoing coronary artery bypass grafting: a randomized, double-blind, placebo-controlled trial 2026-09-10

Vismodegib-loaded ufasomes inhaler for treatment of non-small cell lung cancer 2026-09-10

Berberine inhibits the AcrB efflux pump and synergizes with meropenem against carbapenem-resistant hypervirulent Klebsiella pneumoniae: mechanistic insights and in vivo validation 2026-09-09

CORM-2 protects against sepsis-associated encephalopathy by activating the Nrf2/SLC7A11/GPX4 axis to inhibit ferroptosis and neuroinflammation 2026-09-09

Beyond pooled analysis: sex-specific cardiovascular adverse event reporting signals with antiarrhythmic drugs in FAERS 2026-09-09

Pharmacological activation of dopamine receptor D1 attenuates TGF-β-induced epithelial-mesenchymal transition in A549 and BEAS-2B cells 2026-09-09